{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T14:36:48Z","timestamp":1754145408268,"version":"3.41.2"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,16]]},"DOI":"10.7759\/cureus.88113","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:52:03Z","timestamp":1752713523000},"source":"Crossref","is-referenced-by-count":0,"title":["Chronic Kidney Disease as a Predictor of Mortality in Hospitalized Inflammatory Bowel Disease Patients With Clostridioides difficile Infection"],"prefix":"10.7759","author":[{"given":"Joelle","family":"Sleiman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Gaballa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taimur","family":"Aslam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taqi A","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"El Sayegh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-019-03539-6","article-title":"Clostridium difficile infection: review","volume":"38","author":"Czepiel J","year":"2019","unstructured":"Czepiel J, Dr\u00f3\u017cd\u017c M, Pituch H, et al.. Clostridium difficile infection: review. Eur J Clin Microbiol Infect Dis. 2019, 38:1211-21. 10.1007\/s10096-019-03539-6","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2164","article-title":"Clostridium difficile infection: new developments in epidemiology and pathogenesis","volume":"7","author":"Rupnik M","year":"2009","unstructured":"Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol. 2009, 7:526-36. 10.1038\/nrmicro2164","journal-title":"Nat Rev Microbiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.398","article-title":"The epidemiology of community-acquired Clostridium difficile infection: a population-based study","volume":"107","author":"Khanna S","year":"2012","unstructured":"Khanna S, Pardi DS, Aronson SL, et al.. The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol. 2012, 107:89-95. 10.1038\/ajg.2011.398","journal-title":"Am J Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1306801","article-title":"Multistate point-prevalence survey of health care-associated infections","volume":"370","author":"Magill SS","year":"2014","unstructured":"Magill SS, Edwards JR, Bamberg W, et al.. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014, 370:1198-208. 10.1056\/NEJMoa1306801","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2018.00646","article-title":"Clostridium difficile - from colonization to infection","volume":"9","author":"Sch\u00e4ffler H","year":"2018","unstructured":"Sch\u00e4ffler H, Breitr\u00fcck A. Clostridium difficile - from colonization to infection. Front Microbiol. 2018, 9:646-10.","journal-title":"Front Microbiol"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1017\/ice.2023.18","article-title":"Strategies to prevent Clostridioides difficile infections in acute-care hospitals: 2022 Update","volume":"44","author":"Kociolek LK","year":"2023","unstructured":"Kociolek LK, Gerding DN, Carrico R, et al.. Strategies to prevent Clostridioides difficile infections in acute-care hospitals: 2022 Update. Infect Control Hosp Epidemiol. 2023, 44:527-49.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1403772","article-title":"Clostridium difficile infection","volume":"372","author":"Leffler DA","year":"2015","unstructured":"Leffler DA, Lamont JT. Clostridium difficile infection. N Engl J Med. 2015, 372:1539-48. 10.1056\/NEJMra1403772","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-015-3714-9","article-title":"The risks of incident and recurrent Clostridium difficile-associated diarrhea in chronic kidney disease and end-stage kidney disease patients: a systematic review and meta-analysis","volume":"60","author":"Phatharacharukul P","year":"2015","unstructured":"Phatharacharukul P, Thongprayoon C, Cheungpasitporn W, Edmonds PJ, Mahaparn P, Bruminhent J. The risks of incident and recurrent Clostridium difficile-associated diarrhea in chronic kidney disease and end-stage kidney disease patients: a systematic review and meta-analysis. Dig Dis Sci. 2015, 60:2913-22. 10.1007\/s10620-015-3714-9","journal-title":"Dig Dis Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12672","article-title":"Chronic kidney disease and end-stage renal disease are risk factors for poor outcomes of Clostridium difficile infection: a systematic review and meta-analysis","volume":"69","author":"Thongprayoon C","year":"2015","unstructured":"Thongprayoon C, Cheungpasitporn W, Phatharacharukul P, et al.. Chronic kidney disease and end-stage renal disease are risk factors for poor outcomes of Clostridium difficile infection: a systematic review and meta-analysis. Int J Clin Pract. 2015, 69:998-1006. 10.1111\/ijcp.12672","journal-title":"Int J Clin Pract"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2019.01.001","article-title":"Clostridioides difficile infection in chronic kidney disease\/end-stage renal disease","volume":"26","author":"Ramesh MS","year":"2019","unstructured":"Ramesh MS, Yee J. Clostridioides difficile infection in chronic kidney disease\/end-stage renal disease. Adv Chronic Kidney Dis. 2019, 26:30-4. 10.1053\/j.ackd.2019.01.001","journal-title":"Adv Chronic Kidney Dis"},{"key":"ref11","article-title":"High mortality risk in chronic kidney disease and end stage kidney disease patients with Clostridium difficile infection: a systematic review and meta-analysis","volume":"1","author":"Thongprayoon C","year":"2015","unstructured":"Thongprayoon C, Cheungpasitporn W, Phatharacharukul P, Mahaparn P, Bruminhent J. High mortality risk in chronic kidney disease and end stage kidney disease patients with Clostridium difficile infection: a systematic review and meta-analysis. J Nat Sci. 2015, 1:e85.","journal-title":"J Nat Sci"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2017.06.013","article-title":"Impact of end stage kidney disease on costs and outcomes of Clostridium difficile infection","volume":"62","author":"Goyal A","year":"2017","unstructured":"Goyal A, Chatterjee K, Yadlapati S, et al.. Impact of end stage kidney disease on costs and outcomes of Clostridium difficile infection. Int J Infect Dis. 2017, 62:8-9.","journal-title":"Int J Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000003076","article-title":"Diagnosis and management of Clostridioides difficile in inflammatory bowel disease","volume":"120","author":"Vaughn BP","year":"2025","unstructured":"Vaughn BP, Khoruts A, Fischer M. Diagnosis and management of Clostridioides difficile in inflammatory bowel disease. Am J Gastroenterol. 2025, 120:313-9. 10.14309\/ajg.0000000000003076","journal-title":"Am J Gastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i43.7577","article-title":"Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment","volume":"19","author":"Nitzan O","year":"2013","unstructured":"Nitzan O, Elias M, Chazan B, Raz R, Saliba W. Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment. World J Gastroenterol. 2013, 19:7577-85. 10.3748\/wjg.v19.i43.7577","journal-title":"World J Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.2794","article-title":"Recent developments on the role of Clostridium difficile in inflammatory bowel disease","volume":"14","author":"Freeman HJ","year":"2008","unstructured":"Freeman HJ. Recent developments on the role of Clostridium difficile in inflammatory bowel disease. World J Gastroenterol. 2008, 14:2794-6. 10.3748\/wjg.14.2794","journal-title":"World J Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12425","article-title":"Genetic risk factors for Clostridium difficile infection in ulcerative colitis","volume":"38","author":"Ananthakrishnan AN","year":"2013","unstructured":"Ananthakrishnan AN, Oxford EC, Nguyen DD, Sauk J, Yajnik V, Xavier RJ. Genetic risk factors for Clostridium difficile infection in ulcerative colitis. Aliment Pharmacol Ther. 2013, 38:522-30. 10.1111\/apt.12425","journal-title":"Aliment Pharmacol Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/17562848231207280","article-title":"Inflammatory bowel disease and Clostridium difficile infection: clinical presentation, diagnosis, and management","volume":"16","author":"Bai M","year":"2023","unstructured":"Bai M, Guo H, Zheng XY. Inflammatory bowel disease and Clostridium difficile infection: clinical presentation, diagnosis, and management. Therap Adv Gastroenterol. 2023, 16:17562848231207280. 10.1177\/17562848231207280","journal-title":"Therap Adv Gastroenterol"},{"key":"ref18","doi-asserted-by":"crossref","DOI":"10.2215\/CJN.00950208","article-title":"Aspects of immune dysfunction in end-stage renal disease","volume":"3","author":"Kato S","year":"2008","unstructured":"Kato S, Chmielewski M, Honda H, et al.. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol. 2008, 3:1526-33.","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0000000000000949","article-title":"Clostridium difficile in inflammatory bowel disease","volume":"39","author":"Alhobayb T","year":"2023","unstructured":"Alhobayb T, Ciorba MA. Clostridium difficile in inflammatory bowel disease. Curr Opin Gastroenterol. 2023, 39:257-62. 10.1097\/MOG.0000000000000949","journal-title":"Curr Opin Gastroenterol"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2006.12.027","article-title":"Incidence of Clostridium difficile infection in inflammatory bowel disease","volume":"5","author":"Rodemann JF","year":"2007","unstructured":"Rodemann JF, Dubberke ER, Reske KA, et al.. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007, 5:339-44.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000000968","article-title":"The impact of Clostridium difficile infection on mortality in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"53","author":"Tariq R","year":"2019","unstructured":"Tariq R, Law CC, Khanna S, Murthy S, McCurdy JD. The impact of Clostridium difficile infection on mortality in patients with inflammatory bowel disease: a systematic review and meta-analysis. J Clin Gastroenterol. 2019, 53:127-33. 10.1097\/MCG.0000000000000968","journal-title":"J Clin Gastroenterol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-024-00919-0","article-title":"A systematic literature review on risk factors for and timing of Clostridioides difficile infection in the United States","volume":"13","author":"Eeuwijk J","year":"2024","unstructured":"Eeuwijk J, Ferreira G, Yarzabal JP, Robert-Du Ry van Beest Holle M. A systematic literature review on risk factors for and timing of Clostridioides difficile infection in the United States. Infect Dis Ther. 2024, 13:273-98. 10.1007\/s40121-024-00919-0","journal-title":"Infect Dis Ther"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2006.11.009","article-title":"Immune dysfunction in inflammatory bowel disease","volume":"149","author":"Neuman MG","year":"2007","unstructured":"Neuman MG. Immune dysfunction in inflammatory bowel disease. Transl Res. 2007, 149:173-86. 10.1016\/j.trsl.2006.11.009","journal-title":"Transl Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.12.028","article-title":"Impact of Clostridium difficile on inflammatory bowel disease","volume":"5","author":"Issa M","year":"2007","unstructured":"Issa M, Vijayapal A, Graham MB, et al.. Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007, 5:345-51. 10.1016\/j.cgh.2006.12.028","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjae049","article-title":"Chronic kidney disease in inflammatory bowel disease: a systematic review and meta-analysis","volume":"18","author":"Zadora W","year":"2024","unstructured":"Zadora W, Innocenti T, Verstockt B, Meijers B. Chronic kidney disease in inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis. 2024, 18:1464-75. 10.1093\/ecco-jcc\/jjae049","journal-title":"J Crohns Colitis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1485087","article-title":"Concurrent chronic kidney disease in patients with inflammatory bowel disease, a systematic review and meta-analysis","volume":"11","author":"Han X","year":"2024","unstructured":"Han X, Xu Z, Chang Y, et al.. Concurrent chronic kidney disease in patients with inflammatory bowel disease, a systematic review and meta-analysis. Front Med (Lausanne). 2024, 11:1485087. 10.3389\/fmed.2024.1485087","journal-title":"Front Med (Lausanne)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1159\/000534062","article-title":"Kidney biopsy findings and clinical outcomes of US veterans with inflammatory bowel disease","volume":"3","author":"Ravipati P","year":"2023","unstructured":"Ravipati P, Reule S, Bren A, Bu L, Vaughn BP, Nachman PH. Kidney biopsy findings and clinical outcomes of US veterans with inflammatory bowel disease. Glomerular Dis. 2023, 3:233-40. 10.1159\/000534062","journal-title":"Glomerular Dis"},{"key":"ref28","doi-asserted-by":"crossref","DOI":"10.1093\/ibd\/izac140","article-title":"Renal and urological disorders associated with inflammatory bowel disease","volume":"29","author":"Kumar S","year":"2023","unstructured":"Kumar S, Pollok R, Goldsmith D. Renal and urological disorders associated with inflammatory bowel disease. Inflamm Bowel Dis. 2023, 29:1306-16.","journal-title":"Inflamm Bowel Dis"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/628157","article-title":"Intestinal permeability in inflammatory bowel disease: pathogenesis, clinical evaluation, and therapy of leaky gut","volume":"2015","author":"Michielan A","year":"2015","unstructured":"Michielan A, D'Inc\u00e0 R. Intestinal permeability in inflammatory bowel disease: pathogenesis, clinical evaluation, and therapy of leaky gut. Mediators Inflamm. 2015, 2015:628157. 10.1155\/2015\/628157","journal-title":"Mediators Inflamm"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12020368","article-title":"Altered expression of intestinal tight junctions in patients with chronic kidney disease: a pathogenetic mechanism of intestinal hyperpermeability","volume":"12","author":"Georgopoulou GA","year":"2024","unstructured":"Georgopoulou GA, Papasotiriou M, Bosgana P, et al.. Altered expression of intestinal tight junctions in patients with chronic kidney disease: a pathogenetic mechanism of intestinal hyperpermeability. Biomedicines. 2024, 12:368. 10.3390\/biomedicines12020368","journal-title":"Biomedicines"},{"key":"ref31","article-title":"Control of an outbreak of infection with the hypervirulent Clostridium difficile bi strain in a university hospital using a comprehensive \"bundle\" approach","volume":"45","author":"Muto CA","year":"2007","unstructured":"Muto CA, Blank MK, Marsh JW, et al.. Control of an outbreak of infection with the hypervirulent Clostridium difficile bi strain in a university hospital using a comprehensive \"bundle\" approach. Clin Infect Dis. 2007, 45:1266-73.","journal-title":"Clin Infect Dis"},{"key":"ref32","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10020196","article-title":"Clostridioides difficile infection in chronic kidney disease - an overview for clinicians","volume":"10","author":"Dudzicz S","year":"2021","unstructured":"Dudzicz S, Wiecek A, Adamczak M. Clostridioides difficile infection in chronic kidney disease - an overview for clinicians. J Clin Med. 2021, 10:196.","journal-title":"J Clin Med"},{"key":"ref33","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2012.3507","article-title":"Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis","volume":"307","author":"Newberry SJ","year":"2012","unstructured":"Newberry SJ. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA. 2012, 307:1959-69.","journal-title":"JAMA"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy149","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)","volume":"66","author":"McDonald LC","year":"2018","unstructured":"McDonald LC, Gerding DN, Johnson S, et al.. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018, 66:987-94. 10.1093\/cid\/ciy149","journal-title":"Clin Infect Dis"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1159\/000351757","article-title":"Renal impairment and clinical outcomes of Clostridium difficile infection in two randomized trials","volume":"38","author":"Mullane KM","year":"2013","unstructured":"Mullane KM, Cornely OA, Crook DW, et al.. Renal impairment and clinical outcomes of Clostridium difficile infection in two randomized trials. Am J Nephrol. 2013, 38:1-11. 10.1159\/000351757","journal-title":"Am J Nephrol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.7326\/M16-0271","article-title":"Effect of fecal microbiota transplantation on recurrence in multiply recurrent Clostridium difficile infection: a randomized trial","volume":"165","author":"Kelly CR","year":"2016","unstructured":"Kelly CR, Khoruts A, Staley C, et al.. Effect of fecal microbiota transplantation on recurrence in multiply recurrent Clostridium difficile infection: a randomized trial. Ann Intern Med. 2016, 165:609-16. 10.7326\/M16-0271","journal-title":"Ann Intern Med"},{"key":"ref37","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciab674","article-title":"Real-world comparison of bezlotoxumab to standard of care therapy for prevention of recurrent Clostridioides difficile infection in patients at high risk for recurrence","volume":"74","author":"Johnson TM","year":"2022","unstructured":"Johnson TM, Molina KC, Howard AH, et al.. Real-world comparison of bezlotoxumab to standard of care therapy for prevention of recurrent Clostridioides difficile infection in patients at high risk for recurrence. Clin Infect Dis. 2022, 74:1572-8.","journal-title":"Clin Infect Dis"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.2147\/CEG.S200760","article-title":"Toxic megacolon: Background, pathophysiology, management challenges and solutions","volume":"13","author":"Desai J","year":"2020","unstructured":"Desai J, Elnaggar M, Hanfy AA, Doshi R. Toxic megacolon: Background, pathophysiology, management challenges and solutions. Clin Exp Gastroenterol. 2020, 13:203-10. 10.2147\/CEG.S200760","journal-title":"Clin Exp Gastroenterol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.12.016","article-title":"Identification of patients at risk of Clostridioides difficile infection for enrollment in vaccine clinical trials","volume":"39","author":"Stevens VW","year":"2021","unstructured":"Stevens VW, Russo EM, Young-Xu Y, et al.. Identification of patients at risk of Clostridioides difficile infection for enrollment in vaccine clinical trials. Vaccine. 2021, 39:536-44. 10.1016\/j.vaccine.2020.12.016","journal-title":"Vaccine"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2019.04.009","article-title":"New insights for vaccine development against Clostridium difficile infections","volume":"58","author":"Pizarro-Guajardo M","year":"2019","unstructured":"Pizarro-Guajardo M, Chamorro-Veloso N, Vidal RM, Paredes-Sabja D. New insights for vaccine development against Clostridium difficile infections. Anaerobe. 2019, 58:73-9. 10.1016\/j.anaerobe.2019.04.009","journal-title":"Anaerobe"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/384086-chronic-kidney-disease-as-a-predictor-of-mortality-in-hospitalized-inflammatory-bowel-disease-patients-with-clostridioides-difficile-infection","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:52:05Z","timestamp":1752713525000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/384086-chronic-kidney-disease-as-a-predictor-of-mortality-in-hospitalized-inflammatory-bowel-disease-patients-with-clostridioides-difficile-infection"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":40,"URL":"https:\/\/doi.org\/10.7759\/cureus.88113","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,16]]}}}